Alvotech (ALVO) Total Liabilities (2020 - 2026)
Alvotech (ALVO) posted Total Liabilities of $1.7 billion for Q1 2026, down 3.84% on a QoQ basis from $1.8 billion in Q4 2025, and up 4.24% year-over-year from $1.6 billion in Q1 2025.
Alvotech (ALVO) Total Liabilities (2020 - 2026) Analysis & Trends
Alvotech's Total Liabilities history runs 7 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- Quarterly Total Liabilities rose 4.24% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 4.24% YoY) and the FY2025 annual result came in at $1.8 billion, up 8.41% from the prior year.
- Total Liabilities was $1.7 billion for Q1 2026 at Alvotech, down from $1.8 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $1.9 billion in Q4 2023 and bottomed at $1.1 billion in Q2 2022.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 89.87% — and 2024, when it retreated 13.2%.
- Alvotech's Total Liabilities stood at $1.4 billion in 2022, then surged by 35.16% to $1.9 billion in 2023, then slipped by 13.2% to $1.6 billion in 2024, then advanced by 8.41% to $1.8 billion in 2025, then retreated by 3.84% to $1.7 billion in 2026.
- Business Quant data shows ALVO's Total Liabilities at $1.7 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.63 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Jun 30, 2023 | 1.39 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Dec 31, 2021 | 733.59 Mn |
| Dec 31, 2020 | 534.70 Mn |